Hundreds of transcript isoforms with varying boundaries and alternative regulatory signals are transcribed from the genome, even in a genetically homogeneous population of cells. to study this transcriptional heterogeneity, we developed transcript isoform sequencing (tIF-seq), a method that allows the genome-wide profiling of full-length transcript isoforms defined by their exact 5′ and 3′ boundaries. tIF-seq entails the generation of full-length cDna libraries, followed by their circularization and the sequencing of the junction fragments spanning the 5′ and 3′ transcript ends. By determining the respective co-occurrence of start and end sites of individual transcript molecules, tIF-seq can distinguish variations that conventional approaches for mapping single ends cannot, such as short abortive transcripts, bicistronic messages and overlapping transcripts that differ in lengths. the tIF-seq protocol we describe here can be applied to any eukaryotic organism (e.g., yeast, human), and it requires 6-10 d for generating tIF-seq libraries, 10 d for sequencing and 2-3 d for analysis.
IntroDuctIon
Genome-wide study of transcription has proven invaluable for understanding the mechanisms regulating gene expression and characterizing gene function. However, most of our genome-wide knowledge is based on the study of changes in expression level (i.e., variations in mRNA abundance). Inferring function from expression abundance is based on the simplified assumption that each gene transcribes identical RNA molecules. In reality, one gene may express diverse transcript isoforms by using alternative promoters, exons and terminators 1 . Transcription thus often generates alternative RNA molecules (i.e., isoforms) that differ in length and sequence from each gene. These transcripts can differ markedly in their function, localization and life cycle [2] [3] [4] . Genome-wide methods such as DNA microarrays 5 and RNA-seq 6 have been instrumental in characterizing eukaryotic RNA populations and novel transcript classes 7, 8 . However, these methods only detect the cumulative signal of transcripts overlapping a given genomic region (because they either fragment the RNA or cDNA, or they probe for cumulative signal in specific regions); they cannot resolve the boundaries of individual RNA molecules. Methods that analyze variation of either transcription start sites 9, 10 or polyadenylation sites [11] [12] [13] [14] have indicated considerable variability in transcript boundaries and suggested effects on RNA stability, translation or localization. These methods, however, cannot detect which start sites co-occur with which end sites, a property that determines the functional potential of each RNA molecule 2 .
This led us to develop the approach presented here, TIF-seq, which allows us to concurrently determine the start and end sites of individual RNA molecules within a sample and to discriminate between overlapping molecules 15 . We have investigated transcript isoform variation in Saccharomyces cerevisiae using TIF-seq, showing extensive transcript isoform diversity. This transcript isoform variation affects mRNA stability, localization and translation, or generates truncated versions of proteins that differ in localization or function 15 . Similar approaches based on pairedend sequencing have been previously developed for the study of the transcriptome by Sanger sequencing 16, 17 , and more recently they have been also applied to next-generation sequencing 18, 19 . TIF-seq, also based on next-generation sequencing, avoids initial sample size selection and introduces intermediate amplification steps and molecular barcodes to limit molecular bottlenecks and thus increase sample complexity. This technology has enabled an unprecedented glimpse into the vast transcriptional diversity generated by a genome, with several functional implications, such as variability in mRNA stability, localization or generation of truncated proteins 15 .
Overview of TIF-seq
The TIF-seq procedure can be conceptually divided into four main stages, each of which is described below. 1. RNA oligo capping. The first step of the protocol consists of obtaining an RNA sample suitable for the generation of full-length cDNA (PROCEDURE Steps 1-26 and Fig. 1 ). There are multiple approaches that can be used to select for full-length RNA molecules. Common approaches include cap-trapping 20 , template-switching (e.g., SMART) 21 or oligo-capping methods 22, 23 (reviewed in ref. 24) . We selected the oligo-capping method 23 because it does not entail removing the rRNA in a preceding step, and thus it allows the use of rRNA integrity as a general indicator of RNA quality throughout the process (Fig. 2) . The oligo-capping method consists of the selective ligation of an oligo of known sequence to the previously capped RNA molecules. As a first step, total RNA is dephosphorylated to remove any existing 5′ phosphates (e.g., RNA degradation intermediates). After this step, a treatment with tobacco acid pyrophosphatase (TAP) removes the 5′ cap structure and exposes the 5′ phosphate group necessary for subsequent singlestranded RNA ligation. These two steps are applied to ensure that any noncapped molecules are dephosphorylated before oligo ligation, and thus they guarantee that only previously capped molecules are processed further. Although it is almost impossible to determine the exact number of noncapped RNA molecules present in our final data set, if TIF-seq analysis is focused on the 5′ noncap molecules (i.e., substituting the TAP treatment with a T4 polynucleotide kinase (PNK) treatment 15 ) the obtained profile with respect to the transcription start site is totally different. In addition, background rRNA contamination should be low (i.e., ~20% depending on the sequence mapping approach) and it should correspond mainly to polyadenylated rRNA degradation intermediates 25 . After TAP treatment, an oligo with known sequence is ligated to the 5′ end of the formerly capped RNA molecules. Previous studies have observed that the use of different oligos for single-stranded ligation can lead to substantial differences between samples 26 . Thus, to be able to effectively compare different samples, we chose to avoid any early sample barcoding and to use the same oligo for all samples. In addition, to estimate the accuracy of our 5′ and 3′ end identification, we recommend that capped Step 27) in a high-sensitivity RNA Bioanalyzer run. rRNA peaks (e.g., 18S and 26S for S. cerevisiae) should be clearly visible, and the sample should not be enriched in short RNA molecules that could arise from RNA degradation. FU, fluorescence units. (b) Example of eGel size-selected TIF-seq library analyzed using a high-sensitivity DNA Bioanalyzer ready for sequencing (Step 107). A clear peak should be observed between 270 and 280 nt. Optimal TIF-seq samples should not contain Illumina primer-dimer band (usually located ~130 nt). (c) Example of aligned TIF-seq reads visualized in IGV 33 for S. cerevisiae (data from ref. 15) . Each identified transcript is depicted by a line that connects the 5′ and 3′ end of each transcript isoforms, without any information regarding the internal splicing events. Transcripts are depicted in red (+ strand) and blue (− strand). The overall coverage of each strand is depicted by a gray box. Optimal sample should have high complexity (without a substantial number of PCR duplicates).
and polyadenylated in vitro-synthesized transcripts be used as a 'spike-in' (Box 1). 2. Production of full-length cDNA. Once total RNA has been subjected to the oligo-capping protocol, barcoded full-length cDNA is generated by selectively amplifying RNA molecules with both a 5′ cap structure and a poly(A) tail (PROCEDURE Steps 28-41 and Fig. 1 ). For this procedure, each sample is subjected to reverse transcription (RT) and full-length cDNA generation. Notably, to control for subsequent intermolecular ligation, these reactions are carried out in duplicate (i.e., in two separate tubes) using different sets of oligos, producing equivalent full-length cDNA libraries that should differ only in their terminal barcodes (referred to here as chimera control barcodes A and B). This information will be used after the circularization step to estimate the percentage of intermolecular and intramolecular full-length cDNA ligations (similar to Fullwood et al. 18 ). RNA is subjected to retrotranscription (optimized to produce long cDNA molecules by increasing
Box 1 | Preparation of capped and polyadenylated IVT • tIMInG 6 h
The following protocol describes how to prepare a mix of IVTs that should be added to each sample to control for the quality of 5′ and 3′ exact nucleotide identification. In this case, we use IVTs derived from B. subtilis (ATCC no. 87482 (pGIBS-LYS), ATCC no. 87483 (pGIBS-PHE) and ATCC no. 87484 (pGIBS-THR)) that contain a poly(A) tail encoded in their DNA template. However, in general, any polyadenylated IVT of known sequence that is subsequently capped can be used. reaction time, temperature and by using trehalose combined with an efficient enzyme), followed by a brief PCR amplification using the common sequences added during single-stranded RNA ligation and RT. This initial amplification step is essential to maintain sample complexity (i.e., diversity of isoforms).
In preliminary experiments, where the PCR amplification was omitted and the double-stranded cDNA was directly used in subsequent steps, the complexity of the sample was markedly reduced: the same molecules were sequenced multiple times, producing artifactual homogeneity. This loss in complexity is likely due to a bottleneck in the number of RNA molecules that reach the final library stage, and it can be addressed by performing intermediate sample amplification as described here. Although excessive PCR amplification can also reduce molecular complexity 27 , a few PCR cycles have, in our experience, minimized sample loss and thus effectively enhanced molecular complexity, having enabled us to detect hundreds of thousands of isoforms per sample 15 . Another important consideration for TIF-seq and similar methods (e.g., RNApaired-end tag (PET) 19 ) is the removal of PCR duplicates, as we expect multiple identical isoforms to be transcribed. We have found that the introduction of random barcodes as molecular identifiers ( Fig. 1) during RT allows straightforward identification of PCR duplicates and estimation of library complexity. Specifically, the oligos used for RT (PET-3RT-A and PET-3RT-B, in Table 1 ) contain eight random nucleotides (i.e., 7 N (A, T, C or G) and 1 V (A, C, or G)). Thus, during the data analysis, each transcript will be identified by a specific 5′ and 3′ end and also by a particular random sequence (in green in Fig. 1 ). As this random sequence is introduced before any amplification step, those identified molecules with the same 5′ and 3′ ends, which also contain the same random barcode, can be discarded as PCR duplicates. . 1 ), the circularized full-length cDNA is sonicated, and the junction fragments (which are biotinylated) are purified using magnetic beads. Once the biotinylated sample is bound to the beads, a standard Illumina library is constructed (or according to the sequencing platform used), including DNA blunt ending, dA addition and ligation of forked adapters. In this case, the library remains bound to the streptavidin beads during all steps. If multiple samples are to be run in the same sequencing lane (as we recommend), barcoded forked adapters should be used during the library preparation ( Table 1) . After the enrichment PCR (
Step 99), it is very important to perform an accurate size-selection step (Fig. 2b ). This step is especially important because only a fraction of the sonicated molecules will contain fragments spanning the 5′ and 3′ ends, long enough to uniquely map to the genome and short enough for the sequencing read to identify the exact 5′ and 3′ transcript ends.
Applications of TIF-seq
The TIF-seq method allows the genome wide-unambiguous identification of transcript isoforms by the concurrent sequencing of both 5′ and 3′ ends of individual mRNA molecules. It is designed for the identification of eukaryotic capped and polyadenylated RNA molecules. TIF-seq does not yield information about internal splicing events that do not affect transcription start or termination sites. We have successfully applied it to RNA derived from budding yeast 15 , mouse and human (unpublished data), and it is likely to work in any other eukaryotic organisms. With modifications of the reactions involving the capture of 5′ and 3′ ends, TIF-seq could be tailored to identify alternate populations of transcripts other than polyadenylated and capped RNA (e.g., bacterial mRNAs could be targeted by introducing an artificial poly(A) tail by using Escherichia coli poly(A) polymerase).
Limitations of TIF-seq RNA length bias. One of the main limitations of TIF-seq, or of any other paired-end or full-length cDNA sequencing approach 15, 17, 19, 28 , is the bias toward the identification of short RNA molecules. This bias is also shared by newer sequencing technologies such as PacBio 29 . This has two main consequences: the lack of detection of very long transcripts and the fact that the abundance of short molecules would be overestimated in general. Thus, although the TIF-seq method is well suited for comparing the relative abundance of a given isoform in different conditions, the relative abundance among different isoforms for each gene can be more easily estimated by size-independent methods such as 3′-end mapping 3, 13, 14 . This is especially important for short cryptic RNAs, originating from internal transcription start sites, whose abundance is usually much lower when measured with size-independent 5′-end mapping (V.P., W.W. and L.M.S., unpublished data) than with the TIF-seq approach. In other approaches that use full-length cDNA construction 17, 19 , and which aim to maximize the coverage for long RNAs, short molecules are often eliminated. We intentionally avoided initial size selection of fulllength cDNA to allow for the detection of small overlapping RNAs (e.g., short coding RNAs (scRNAs) 15 ). If desired, however, the differential chimera barcoding during the full-length cDNA generation step can be exploited to simultaneously perform nonsize-selected and long-molecule-enriched protocols in parallel (as described at PROCEDURE Step 42). Thus, TIF-seq is a quantitative method when comparing the same isoform in two different conditions, but it should not be used to compare expression levels among different transcripts.
Reverse transcriptase template switching. Although previous studies have used similar techniques to identify interchromosomal transcripts 17, 19 , we found that most instances of interchromosomal transcripts arose from the apparent fusion of highly expressed families of transcripts with high sequence homology 15 .
The presence of sequence homology between transcripts, along with the propensity of reverse transcriptase to perform template switching between homologous templates 30 , suggests that the most common origin of these apparently fused transcripts is artifactual. Thus, TIF-seq, and all methods involving RT (e.g., RNA-seq), are technically limited in their ability to detect fused transcripts.
Number of usable reads.
It is important to note that only a relatively small fraction of the reads produced by TIF-seq will contain fragments at the 5′ and 3′ ends that are long enough to map to the genome and short enough for the sequencing read to contain both the 5′ and 3′ transcript ends (e.g., from 5-10%). Thus, the coverage level that can be obtained by TIF-seq is substantially lower than the coverage typically obtained by other single-end-specific methods. In general, we multiplex 2-3 S. cerevisiae samples per HiSeq 2000 lane (i.e., ~50 million raw reads per sample), although depending of the study purpose deeper sequencing could be advisable.
In general, sequencing depth should be between 5 and 10 times higher than for a standard RNA-seq experiment. The use of longer sequencing reads (i.e., increasing from 100 to 150 bp) and/or libraries with larger fragments would probably increase the percentage of usable reads (up to two times more uniquely mapped reads in our preliminary experiments (V.P., A.I. Järvelin, W.W. and L.M.S., unpublished data)). It is therefore important to sequence sufficiently deeply, as the quantification of subtle differences in medium or low expression levels remains challenging when one has low counts 31 , especially if boundary clustering is not used or only moderately used. When absolute quantification is the goal instead of charting transcriptomic architecture, TIF-seq could be complemented with independent methods for 5′-or 3′-end mapping to increase the read coverage and to thus improve its quantitative power 17 .
Frequency of NotI recognition site.
NotI, which is used during the generation of circularized cDNA molecules, recognizes the sequence 5′-GCCGGCCGC-3′, which is extremely rare in the AT-rich (61.7%) yeast genome, but its increased frequency in other organisms could decrease the number of TIFs detected for genes neighboring or containing it. In theory, this problem could be addressed by selectively adding 5-methyl-dCTP during RT; however, alternative protocol variants including DNA hemimethylation were not effective in our experience. Another solution would therefore be to select a different enzyme for genomes with a higher frequency of the NotI recognition sequence.
Analysis of cellular population. It is important to note that TIF-seq is not a single-cell transcriptomics approach. Thus, it cannot distinguish whether the detected transcript isoforms co-occur within the same cell or whether they are present in different subcellular populations. 
Box 2 | Preparation of annealed linkers • tIMInG 2 h
To produce double-stranded DNA linkers, it is necessary to mix the forward and reverse oligos (table 1) and to subject them to heat denaturation followed by slow cooling to facilitate annealing between the single-stranded molecules.  crItIcal step The addition of capped and polyadenylated in vitro transcripts (IVTs; Box 1) is crucial for quality control of the whole process, allowing experimental artifacts to be eliminated. The information obtained from the IVTs will be used to assess the technical precision of the 5′ and 3′ end mapping, rather than their respective amount (as IVT read counts will be also influenced by their different length, see 'Limitations' section in the INTRODUCTION).  crItIcal step In all steps involving RNA manipulation, it is important to work in an RNase-free environment, to use gloves and to maintain the samples on ice when possible.  crItIcal step We have successfully produced TIF-seq libraries starting from as little as 10 µg of total RNA. Potentially, this amount could be further decreased as long as a complex full-length cDNA library is obtained. In a similar protocol based also on RNA ligation in which only the 5′ end is captured, we have successfully decreased the required starting amount to 500 ng of total RNA (V.P., W.W. and L.M.S., unpublished data). However, to successfully decrease the starting RNA amount, it would be required to further improve the efficiency of RNA ligation and full-length cDNA RT.
2| Add 6 µl of DNase inactivation reagent (Invitrogen) and flick the tubes. Incubate the tubes for 2-3 min at room temperature.
3|
Centrifuge the tubes at 16,000g at room temperature for 2 min, and recover the supernatant.  crItIcal step It is important to keep a small aliquot (e.g., 0.5 µl) of every step involving RNA manipulation to check the RNA integrity in an agarose or Bioanalyzer RNA gel after the specific manipulation. Once the protocol has been performed successfully several times, controls could be restricted to the quality control of initial RNA and after single-stranded RNA ligation (Step 26). ? trouBlesHootInG phosphatase treatment • tIMInG 4 h 4| Remove the 5′ phosphate of the fragmented and noncapped (5′ triphosphate) molecules by setting up the following 100-µl reaction in a 1.5-ml tube: 
6|
To remove the phosphatase, increase the sample volume with RNase-free water to 150 µl, and transfer it to a light phase-lock tube (1.5 ml) containing 150 µl of water-saturated phenol. Mix the phases by flicking the tube, and separate them by centrifugation for 3 min at 10,000g at room temperature.
7|
Transfer the aqueous phase to a new light phase-lock tube (1.5 ml) containing 150 µl of water-saturated phenol to perform a second extraction. Mix the phases by flicking the tube, and separate them by centrifugation for 3 min at 10,000g at room temperature.  crItIcal step We perform a double phenol extraction to make sure that no phosphatase activity remains in the sample, as it could interfere with downstream steps.
8| By using light phase-lock tubes (1.5 ml), perform one extraction using an equal volume of phenol:chloroform:isoamyl alcohol 24:25:1 (150 µl). Mix the phases by flicking the tube, and separate them by centrifugation for 3 min at 10,000g at room temperature. 
10|
Precipitate the sample by centrifugation for 30 min at 14,000g at 4 °C.
11|
Wash the pellet with 300 µl of ice-cold 70% (vol/vol) ethanol.
12|
Centrifuge the sample for 10 min at 14,000g at 4 °C.
13|
Remove the remaining ethanol and resuspend the pellet in 16.3 µl of RNase-free water.  crItIcal step In this and all subsequent nucleic acid precipitation steps, any excess of ethanol should be removed before resuspending the sample in water. However, excessive drying of the pellet should also be avoided, as it will make the pellet difficult to resuspend. 
5′ cap removal • tIMInG 4 h 14|

15|
Incubate the sample for 1 h at 37 °C.
16|
To remove the TAP enzyme, increase the sample volume with RNase-free water to 150 µl, and transfer it to a light phase-lock tube (1.5 ml) containing 150 µl of phenol:chloroform:isoamyl alcohol at a 24:25:1 ratio. Mix the phases by flicking the tube, and separate them by centrifugation for 3 min at 10,000g at room temperature.
17| Ethanol-precipitate the aqueous phase by adding 2.5 volumes (with respect to the sample volume) of 100% (vol/vol) ethanol, a one-tenth volume of 3 M sodium acetate and 1 µl of linear acrylamide (5 mg ml −1 ). Mix and incubate them on ice for a minimum of 20 min.  pause poInt The precipitation maybe left overnight at −20 °C.
18|
Precipitate the sample by centrifugation for 30 min at 14,000g and 4 °C.
19| Wash the pellet with 300 µl of ice-cold ethanol 70% (vol/vol).
20|
Centrifuge the sample for 10 min at 14,000g and 4 °C.
21|
Remove the remaining ethanol and resuspend the pellet in 4.  crItIcal step The addition of polyethylene glycol (PEG) supplied with the T4 RNA ligase 1 will result in RNA precipitation during the ligation at 16 °C. If PEG is used the ligation might be performed at a higher temperature for a shorter time (e.g., 2 h at 25 °C). However, we routinely prefer the use of longer incubations at 16 °C and therefore omit PEG from the reaction.  crItIcal step The single-stranded RNA ligation is a relatively inefficient step. Always use DNA or RNA oligos in which at least the last eight bases are ribonucleotide triphosphates (rNTPs). We prefer the use of a single oligo for all the samples rather than the use of barcoded oligos (e.g., for early multiplexing), as the latter may introduce biases between libraries during the ligation step 26 .
23| Purify the sample using 1.8× volumes of Ampure XP beads according to the manufacturer's instructions and as outlined here (Steps 23-24). Add 18 µl of Ampure XP beads and mix the sample by pipetting up and down. Let the sample bind the beads by incubating the mixture at room temperature for 5 min.  crItIcal step All volumes of Ampure XP beads refer to bead slurry, as described by the manufacturer.
24| Place the 0.2-ml tubes in the magnet and let the beads settle (~2 min). Remove the supernatant and perform two consecutive washes with 200 µl of 70% (vol/vol) ethanol.  crItIcal step Please note that, as described by the manufacturer, ethanol washes of Ampure XP beads should always be performed on the magnet without resuspending the beads.
25|
Remove the ethanol and allow the beads to slightly dry for 1 min. Elute the sample in 25 µl of RNase-free water. Retain a 1-µl aliquot for quality control.  pause poInt The eluted sample may be stored for weeks at −80 °C.
26|
It is extremely important to confirm that the integrity of the RNA sample was maintained during the enzymatic treatment of the RNA. Run an Agilent RNA Bioanalyzer comparison of the input (aliquot from total RNA, Step 1) and the ligated RNA sample (from Step 25) . If substantial degradation is observed (e.g., more intense 18S than 26S or an excess of short-length RNAs), discard the sample. See Figure 2a for an example. ? trouBlesHootInG reverse transcription • tIMInG 2.5 h 27| Split each ligated RNA sample into two independent 0.2-ml tubes (tubes 1 and 2) with 10 µl of sample in each, and proceed in parallel; these tubes will be processed in parallel until the circularization of the full-length cDNA (Step 43), when the contents will be combined.  crItIcal step Splitting the samples in two is necessary to control for intramolecular versus intermolecular ligations. Detailed explanation of the motivation can be found in the Experimental design section.  crItIcal step Use oligo PET-3RT-A for tube 1 and PET-3RT-B for tube 2. Those oligos contain specific barcode sequences that will be used to control for intermolecular ligations events.
29|
Denature the samples at 65 °C for 5 min. Afterward, place the samples on ice.
30|
To each tube, add 11 µl of mixture containing the following:  crItIcal step Do not add actinomycin D, as it will prevent the RT of the DNA part of the 5RNAGsuI oligo. In this protocol, strand specificity is maintained by the relative orientation of oligos that are specifically added to the 5′ and 3′ mRNA side.
31|
Mix the sample and incubate it for 2 min at 42 °C. While the samples are in the PCR machine, add 2 µl of SuperScript III reverse transcriptase (Invitrogen) to each sample. Incubate the samples at 42 °C for 50 min; at 50 °C for 30 min; and at 55 °C for 30 min; next, inactivate at 70 °C for 15 min.
Hold the samples at 4 °C.  crItIcal step One of the limiting steps of TIF-seq and any other protocol requiring the generation of full-length cDNA molecules 15, 17, 19, 28, 29 is the efficient production of long cDNAs. Any modification improving this step will further contribute to the overall method efficiency.
32|
Remove the template RNA and excess of rRNA by adding 1 µl of the following mix and by incubating at 37 °C for 30 min.  crItIcal step Tube 1 should contain primer pair PET-5ABio/PET-3A, and tube 2 should contain primer pair PET-5BBio/ PET-3B. The different primer pairs contain specific barcode sequences that will be used to control for intermolecular ligations events. By performing the reactions in two different tubes, we make sure that only two specific combinations of barcoded full-length cDNA molecules are being produced (i.e., PET-5ABio/PET-3A and PET-5BBio/PET-3B).
37| Run a PCR with the following cycling conditions, and then hold the samples at 4 °C. 
38|
Pool the samples from tubes 1 and 2 and purify them using 1.8× volumes of Ampure XP beads according to the manufacturer's instructions and as described here (Steps 38-40). Add 180 µl of Ampure XP beads and mix the sample by pipetting up and down. Let the sample bind the beads by incubating at room temperature for 5 min.
39| Place the 0.2-ml tubes in the magnet and let the beads settle (~2 min). Remove the supernatant and perform two consecutive washes with 200 µl of 70% (vol/vol) ethanol.
40|
Remove the ethanol and let the beads slightly dry for 1 min. Elute the sample in 13 µl of EB buffer (10 mM Tris-HCl, pH 8.0).
41|
Quantify the produced full-length cDNA by using the Qubit with the dsDNA HS assay kit. Usually ~300 ng of full-length cDNA is obtained.  crItIcal step Although TIF-seq can be performed without any PCR amplification of the full-length DNA, skipping the PCR amplification will lead to a molecular bottleneck that will decrease sample complexity and thus artifactually produce an apparently homogeneous population. Only a small amount of the mRNAs will produce full-length cDNA (first molecular bottleneck), and subsequently only a small amount of it will be circularized and will produce a final library (second molecular bottleneck). By introducing an amplification step (PCR) between those two bottlenecks, we avoid the number of molecules becoming too low, which would consequently lead to a big loss of library complexity. In addition, as we are including a random barcode during the RT step, it will be possible to correct for any PCR duplicates produced during this step.
 pause poInt The sample may be stored for months at −20 °C.
size selection (optional)
• tIMInG 4 h 42| If required, enrich the TIF-seq libraries for longer mRNA molecules (e.g., >2 kb) by performing gel-based size selection, as described in Box 3 and Figure 3 . production of sticky ends • tIMInG 1.5 h 43| Combine ~300 ng of full-length cDNA from tube 1 and tube 2 containing different chimera barcodes in a volume of <16 µl.  crItIcal step If size selection has been performed (Box 3) for any of the full-length samples, it is possible to mix them in a ratio different from 1:1. For example, combine 200 ng of non-size-selected full-length cDNA (putatively shorter) with 300-ng size-selected (long) full-length cDNA.
44|
Increase the full-length cDNA sample volume to 15.8 µl with water and set up the following 20-µl reaction. 
Box 3 | Optional size selection to enrich for longer mRNAs • tIMInG 4 h
To enrich the TIF-seq libraries for longer mRNA molecules (e.g., >2 kb), it is possible to perform gel-based size selection followed by a second PCR amplification. This can be done for both tube 1 and 2 or only for one of the barcoded fractions of full-length cDNA (e.g., tube 2). In general, to avoid losing the population of short RNAs (e.g., scRNAs) 15 , we recommend performing the size selection for only one of the fractions (i.e., tube 2). In this case, the initial PCR amplification of the full-length cDNA molecules at Step 36 of the main PROCEDURE can be performed with the nonbiotinylated version of the oligos (e.g., PET-5A or PET-5B); the biotin can be introduced in the second PCR (step 5 of this box).
1. Run the full-length cDNA sample on a 1.5% (wt/vol) agarose 1× TBE gel. 2. Use a clean scalpel to excise a gel fragment corresponding to high-molecular-weight cDNAs (longer than 1.5-2 kb); it is useful to use the xylene cyanol band of the loading buffer dye as a reference (Fig. 3) .  crItIcal step To minimize full-length cDNA fragmentation, do not irradiate the gel with UV until the DNA sample is removed. 3. Extract DNA using the Qiagen MinElute gel extraction kit according to the manufacturer's instructions. 10. Quantify the produced size-selected full-length cDNA using the Qubit with the dsDNA HS assay kit. Usually ~300 ng of full-length cDNA is obtained.  crItIcal step It is advisable to check the sizes of the produced full-length cDNA molecules (both initial and gel-size selected) by high-sensitivity DNA Bioanalyzer (Agilent).
 crItIcal step NotI enzyme will also cut any molecules where its recognition sequence (5′-GCCGGCCGC-3′) is present. Bioinformatic analysis of the genome of interest should be performed to ensure that the digestion would not deplete a specific gene of interest.
45|
Incubate the sample for 1 h at 37 °C in a thermocycler block with a heated lid. 51| Incubate the sample overnight at 16 °C (minimum of 16 h).  crItIcal step To minimize the appearance of chimeric molecules, the final concentration of full-length cDNA in the sample should be equal to or <1 ng µl −1 . The circularization process is not very efficient, so as much full-length cDNA as possible should be used-preferentially 600 ng or more, but not <300 ng. Lowering the concentration of T4 DNA ligase used can decrease the efficiency of the process. In our previous experiments 15 , we obtained ~0.19% intermolecular ligation events after bioinformatic filtering (i.e., defining a maximum insert size of 5 kb and requiring both ends to map to the same chromosome), or ~4% before any bioinformatic filtering 15 .
52| Incubate the samples for 5 min at room temperature to close any remaining DNA nicks in the circularized full-length cDNA.
53|
Treat the samples with Plasmid-Safe to remove any remaining noncircularized full-length cDNA. Add 0.2 µl of Plasmid-Safe for each 100 µl of the ligation reaction (e.g., 1.2 µl for the 600-µl ligation reaction tube).
54|
Incubate the sample for 30 min at 37 °C and then inactivate it by incubation for 30 min at 70 °C. 
55|
Remove the enzyme by phenol-chloroform extraction. To a 2-ml heavy phase-lock tube, add equal volumes of sample and phenol:chloroform:isoamyl alcohol at a 25:24:1 ratio (600 µl each). Mix the phases by flicking the tube, and separate them by centrifugation for 5 min at 10,000g at 25 °C.
56|
Isopropanol-precipitate the sample by adding 0.7 volumes (with respect to the sample volume) of 100% isopropanol, a one-tenth volume of 3 M sodium acetate and 1 µl of linear acrylamide. Mix and incubate the sample at 4 °C for a minimum of 20 min.
 pause poInt The precipitation may be left overnight at −20 °C.
57|
58|
Wash the pellet with 300 µl of 70% (vol/vol) ice-cold ethanol.
59|
Centrifuge the sample for 10 min at 14,000g at 4 °C. 63| Purify the sample using 1.8× volumes of Ampure XP beads according to the manufacturer's instructions and as described here (Steps 63-65). Add 18 µl of Ampure XP beads and mix the sample by pipetting up and down. Let the sample bind the beads by incubating at room temperature for 5 min.  crItIcal step Ampure purification is essential to remove from the sample biotinylated fragments that are too short to be informative (i.e., shorter than 100 bp).
64| Place the 1.5-ml tubes in the magnet and let the beads settle (~2 min). Remove the supernatant and perform two consecutive washes with 200 µl of 70% (vol/vol) ethanol.
65|
Remove the ethanol and let the beads slightly dry for 1 min. Elute the sample in 20 µl of EB and transfer it to a 0.2-ml tube.
66|
Check the concentration using the Qubit fluorometer with the dsDNA HS assay kit (optimally should be ~10 ng per sample).  crItIcal step Do not pause sample preparation after sonication, but proceed immediately to the next step.  crItIcal step Sonication seems to fragment more frequently in the poly(A) tail region, and thus the relative AT content of the genome could affect the specific fragmentation.
Binding samples to streptavidin beads • tIMInG 1 h 67| Prepare M-280 streptavidin beads (Invitrogen) according to the manufacturer's instructions and as described in Steps 67-69. First, transfer 20 µl of beads into a 0.2-ml tube.
68| Place the 0.2-ml tubes in the magnet and let the beads settle (~2 min). Remove the supernatant and perform two consecutive washes with 200 µl of 1× B&W buffer.
69|
Resuspend the beads in 20 µl of 2× B&W buffer (10 mM Tris-Cl (pH 7.5), 1 mM EDTA (pH 8.0) and 2 M NaCl).
70|
Add to the beads 20 µl of sonicated circularized full-length cDNA (from Step 65), and let the samples bind by incubating the beads in a rotator wheel for 30 min at room temperature. Please note that the wheel rotation will not mix the 40-µl bead solution, but rather prevent the beads from settling down.
71| Place the 0.2-ml tubes in the magnet and let the beads settle (~2 min). Remove the supernatant.  crItIcal step To minimize the production of primer dimers in subsequent steps, it is critical to keep the concentration of linkers as low as possible. If a low amount of sample is expected, the concentration of linker should be decreased to minimize primer-dimer generation.  crItIcal step If no multiplexing is to be performed and only one sample is going to be sequenced per lane, standard nonbarcoded oligos should be used. Otherwise, the lack of sequence complexity during the first sequencing cycles will lead to decreased cluster identification and potentially a failed sequencing run.
88|
Incubate the sample for 60 min at room temperature.
89| Place the 0.2-ml tubes in the magnet and let the beads settle (~2 min). Remove the supernatant.
90|
Perform three consecutive washes with 200 µl of 1× B&W buffer, letting the beads settle each time.
91|
With the last wash, change the beads containing the sample to a new 0.2-ml tube, and then let the beads settle (~2 min). Remove the supernatant. 98| Purify the sample using 1.8× volumes of Ampure XP beads according to the manufacturer's instructions and as described here (Steps 98-100). Add 90 µl of Ampure XP beads, and mix the sample by pipetting up and down. Let the sample bind the beads by incubating at room temperature for 5 min.
111|
Align the read pairs to four configuration sequences (chimera control configurations; table 2) using the NeedlemanWunsch global alignment method provided by the R Biostrings package from Bioconductor (http://bioconductor.org/).
112|
Assign each pair to a configuration on the basis of the best unique alignment to the four sequences in table 2. Keep only those in which the orientation between the two reads agree in a way that one maps to forward sequences and the other to reverse sequences of one configuration. In addition, at least one read in a pair should have an alignment score >25 and at least six As in the poly(A) sequences should be present in the alignment.  crItIcal step Note that the number of As present in the poly(A) sequences in the library can vary during the multiple PCR amplifications owing to polymerase slippage.
113|
Trim the 8 nt located downstream of the poly(A) sequences, corresponding to the random molecular barcodes. Use them to identify unique transcriptional events and eliminate amplification bias.
114|
Trim the pairs of 5′ and 3′ sequences independently according to their alignments to configuration sequences. Only the sequences containing at least 20 bp at both the 5′ and 3′ ends should be kept for further alignment.
115|
Align pairs of 5′ and 3′ sequences separately to the reference genome using Novoalign V2.07.10 (http://www.novocraft.com) with default parameters. A reference genome containing both the genome sequence along with the sequences of the IVTs included as spike-in controls should be used. Configuration B-A(chimera) 3′ end-AAAAAAAAAAAAAAAABnnnnnnnAGATGCGGCCGCACTGCACTCTGAGCAATACC-5′ end 3′ end and 5′ end correspond to the regions where the cDNA sequence will be present. Random barcodes are identified in bold, 3′-and 5′-chimera barcodes are underlined (left and right, respectively), the NotI recognition sequence is in italics, and the poly(A) tail and common sequence ligated to the 5′ RNA end are in regular font (left and right, respectively). Sequences are represented in 5′-3′ orientation. 
116|
antIcIpateD results
This protocol will produce sequencing reads that contain the information necessary to identify both 5′ and 3′ ends of transcripts. Both ends can be connected by, and visualized in, programs such as Integrative Genomics Viewer (IGV) 33 (Fig. 2c) .
In Figure 2 , each identified transcript isoform corresponds to a line that connects the 5′ and 3′ end of each molecule, without any information regarding the internal splicing events. The analysis of the TIF-seq reads mapping to the IVT spike-ins (Box 1) is a useful tool to check for the technical success of the protocol. In general, >90% of the reads assigned to the IVTs should map in close proximity (<5 nt window) to their known 5′ and 3′ ends. Please note that, as explained previously in the limitation sections, the identification of shorter transcripts is favored. Thus, it is common to detect short transcripts initiating in the body of the gene and ending in the expected polyadenylation site (e.g., as is the case for MRPL24 in Fig. 2c ). Those transcripts, although overrepresented by TIF-seq, do exist in the sample, and they can also be observed when size-independent mapping of the 5′ cap is performed. If in a particular TIF-seq study the objective is to focus in the longer RNA molecules, optional size selection of the full-length cDNA is recommended (Box 3). It is also expected to detect significant heterogeneity for the presence of alternative 5′ and 3′ ends (when compared with the technical detection heterogeneity associated with the IVTs). A decreased heterogeneity is usually due to a lack of library complexity.
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